id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1401276,22cf9f9b-6729-4ca8-8839-7b4d2c58d19f,2T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2013,second_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-05-20T16:11:08.293000-04:00
1401280,62a95ebf-7a7c-45a2-83b0-2db37e871756,2T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2013,second_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-05-20T16:20:10.977000-04:00
1401284,997802ff-308f-43af-8df5-bbef2d10ffc3,2T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2013,second_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-05-20T16:34:13.347000-04:00
1401290,784014c6-1a40-482c-9cc6-cc890ab5188b,2T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2013,second_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-05-20T16:45:15.340000-04:00
1401310,97180f1b-de8b-4e10-9e7c-456baf7320eb,2T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2013,second_quarter,MED,Issues related to the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2013-05-20T17:05:18.880000-04:00
1401601,5aa2945d-ad75-49fa-b7dd-634dc5f9ddeb,2A,AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS,1375,AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS,2013,second_quarter,MED,Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ),"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE",,,0,0,2013-06-05T14:06:36.930000-04:00
1401723,5b60f187-152a-4385-9dd8-8dc56a98d97c,Q2,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2013,second_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2013-06-19T09:52:05.830000-04:00
1401732,1c90bb0c-d9b0-4b3d-9dbb-4fe9b8b0e251,Q2,COLBY & COMPANY,400394858,BIOOHIO,2013,second_quarter,MED,Urge repeal of medical device tax,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-06-19T15:12:06.920000-04:00
1401741,019c8cf5-aa8d-4a9d-b516-c68cd1256788,2A,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2013,second_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2013-06-20T10:55:23.440000-04:00
1401832,dee33fbc-d954-4181-98ab-2b436e71c264,Q2,PALMETTO GROUP,18570,INTERNATIONAL AIDS VACCINE INITIATIVE,2013,second_quarter,MED,"Federal Funding of AIDS vaccine
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014",SENATE,22500,,0,0,2013-06-27T11:10:22.397000-04:00
1401953,0724a715-da5e-4aec-a4b1-60a6152e8400,Q2,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2013,second_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2013-07-01T00:31:34.430000-04:00
1402064,40e23c88-9060-4589-9914-9978074402f3,Q2,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2013,second_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",46000,,0,0,2013-07-01T14:48:26.817000-04:00
1402072,dad5fd86-1e44-4f5a-814f-4280b173ae97,Q2,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2013,second_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",46000,,0,0,2013-07-01T15:30:30.970000-04:00
1402297,c8718f45-8365-4fba-80ed-139390f0a5bc,Q2,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2013,second_quarter,MED,all matters dealing with pharmaceutical labeling,Food & Drug Administration (FDA),25000,,0,0,2013-07-02T13:17:35.603000-04:00
1402381,23d0445c-8fca-4231-add5-a91ce0774bb5,Q2,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2013,second_quarter,MED,"Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally.  Contacted VA and House and Senate about regulations for reprocessed single-use medical devices.","HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,,0,0,2013-07-02T14:51:16.777000-04:00
1402389,452ecc49-8bd4-45e7-b2c4-f7e120002f03,2T,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PATH,2013,second_quarter,MED,Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2013-07-02T14:54:20.370000-04:00
1402454,4670cda4-d6af-4311-b1bd-61e74dbf7a6a,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2013,second_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,111725,0,0,2013-07-02T16:07:53.320000-04:00
1402971,94424604-238f-4d75-a555-3838deaf0c7e,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,AMERICAN BRAIN TUMOR ASSOCIATION,2013,second_quarter,MED,Issues and legislation related to brain tumors and brain tumor research.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office",10000,,0,0,2013-07-05T15:08:26.990000-04:00
1402973,1370b257-b431-4cea-b064-3c62b2d8503b,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2013,second_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office",10000,,0,0,2013-07-05T15:14:28.890000-04:00
1403235,8bb0490d-8531-450f-8557-c87606ae1355,Q2,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2013,second_quarter,MED,"FY 2012 Appropriations
Residency Caps
Minority Improvement
NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers
Resident Physician Shortage
Health Care Reform
FY 2013 Appropriations
FY 2014 Appropriations","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)",,29312,0,0,2013-07-08T12:52:43.863000-04:00
1403809,abcae3ae-d48b-480e-8ef8-74d66e185031,Q2,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2013,second_quarter,MED,"Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-07-09T16:01:34.570000-04:00
1403823,24f00c8b-42df-4322-90a0-bfc3b47d6487,Q2,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2013,second_quarter,MED,Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research,"Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2013-07-09T16:05:38.377000-04:00
1404046,b103747f-330f-46da-a57d-5c8967aadc96,Q2,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2013,second_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-10T11:25:29.707000-04:00
1404277,4de74c96-248c-4210-bc95-7cd406dc1558,Q2,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2013,second_quarter,MED,NIH Budget including Title VII & VIII programs-Sequestration,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,145000,0,0,2013-07-10T14:23:46.640000-04:00
1404640,f5f2e7f7-6d54-429c-96a3-2e4607520f8b,Q2,"HARRISON RIVARD DUNCAN & BUZZETT, CHTD.",72257,HCA HEALTHCARE,2013,second_quarter,MED,Health and Medical Issues,,,,0,0,2013-07-11T10:17:52.227000-04:00
1404796,837428c3-5f0d-4695-a826-5f04ac50761e,Q2,LNE GROUP,308811,GOJO INDUSTRIES,2013,second_quarter,MED,Lobbied on issues regarding medical industry,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-11T11:55:07.697000-04:00
1404808,1a4919b1-8c69-4be0-b3f4-28eea72499a7,Q2,LNE GROUP,308811,OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE),2013,second_quarter,MED,"Lobbied for issues within the medical field including reseach, and clinical labs","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-11T12:00:13.973000-04:00
1404909,4b7bafcc-e48a-4c33-81dc-14a23b2acfe7,Q2,LNE GROUP,308811,INTRINSIQ MATERIALS,2013,second_quarter,MED,Lobbied for issues regarding the medical research,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-11T12:48:43.403000-04:00
1404965,7004c4d4-183c-42af-b6c7-e43cea4738fb,Q2,LNE GROUP,308811,PARKER HANNIFIN,2013,second_quarter,MED,Lobbied on issues regarding the medical field/disease research/clinical labs,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2013-07-11T13:11:02.493000-04:00
1405005,3d83962d-9d8f-40ad-85c4-56e90bdd76dc,Q2,LNE GROUP,308811,ZIMMER,2013,second_quarter,MED,Lobbied for medical device issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-11T13:30:13.010000-04:00
1405115,0b38c9dc-2823-4137-9aa0-2e81237feec1,Q2,MASSACHUSETTS MEDICAL SOCIETY,23975,MASSACHUSETTS MEDICAL SOCIETY,2013,second_quarter,MED,Reclassification of marijuana so that its potential medicinal use by humans may be studied and potentially regulated by the FDA,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE",,60000,0,0,2013-07-11T14:58:10-04:00
1405134,e5add7ca-188f-4919-863b-f9043eef2686,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2013,second_quarter,MED,FDA regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-11T15:05:17.247000-04:00
1405226,e81b1070-989b-4d91-8167-c9dcbed73d37,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2013,second_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014.  Support funding for medical treatments for HIV positive patients.  Support appropriate funding for the ADAP program.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-11T16:00:55.187000-04:00
1405702,8f3968c1-3393-4162-9654-fde198e222a9,Q2,GRIZZLE COMPANY,16987,UNIVERSITY OF LOUISVILLE,2013,second_quarter,MED,Support for PICORI grant application.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-07-12T13:52:19.177000-04:00
1405729,576d254c-3cff-40b1-adce-2100df8785cb,Q2,"DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO",12094,DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO,2013,second_quarter,MED,Strategies to Address Antimicrobial Resistance Act (H.R. 2285).,"Commerce, Dept of (DOC),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Endowment for the Arts,SENATE,U.S. International Trade Commission (ITC)",,30000,0,0,2013-07-12T14:05:27.683000-04:00
1405967,59c68b6b-0506-4330-9d9d-f73943d12479,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,COALITION FOR 21ST CENTURY MEDICINE,2013,second_quarter,MED,Issues concerning regulation of laboratory tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2013-07-12T15:57:38.157000-04:00
1406222,6e585274-f1bf-4f64-8229-84850b4590e0,Q2,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2013,second_quarter,MED,"Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative.
Support for full funding of NIH","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",20000,,0,0,2013-07-13T10:06:57.010000-04:00
1406229,10dfddcf-ed87-4467-a6ae-8df7a5404a05,Q2,BEN BARNES GROUP LP,5415,FAIR LABORATORY PRACTICES ASSOCIATION,2013,second_quarter,MED,Bring attention to prevention of unfair billing practices by laboratories for Medicare services,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-13T11:31:01.467000-04:00
1406251,b8bc5ebe-8908-4f6a-be06-aec281cc06e2,Q2,BEN BARNES GROUP LP,5415,"ROYALTY PHARMA - / RP MANAGEMENT, LLC",2013,second_quarter,MED,"Tax Reform, Master Limited Partnership","HOUSE OF REPRESENTATIVES,SENATE",150000,,0,0,2013-07-13T13:38:15.930000-04:00
1406267,9de656e7-9fc3-4ce8-957a-9cabf730f2ba,Q2,BEN BARNES GROUP LP,5415,TEXAS A&M SYSTEM,2013,second_quarter,MED,"Assost the Texas A&M System in pursuit of various projects, general government relations","HOUSE OF REPRESENTATIVES,SENATE",37500,,0,0,2013-07-13T14:05:19.217000-04:00
1406336,9e205ce0-7f62-4028-a1e0-5e2c25a3dd81,Q2,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2013,second_quarter,MED,"Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma.","Defense, Dept of (DOD)",30000,,0,0,2013-07-14T12:12:09.070000-04:00
1406370,568f807a-8d43-4fe5-926d-6a322ed97e0f,Q2,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2013,second_quarter,MED,"Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding.  
Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-14T16:40:27.997000-04:00
1406768,6e4c3883-716f-4ed1-a1eb-362a6b86ddc8,Q2,AMERICAN SOCIETY FOR MICROBIOLOGY,3355,AMERICAN SOCIETY FOR MICROBIOLOGY,2013,second_quarter,MED,Part B Clinical Laboratory Fee Schedule,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-15T13:13:33.107000-04:00
1407127,a7c8b2a7-df36-4d11-b375-7c1ff7b18d70,Q2,PERSONALIZED MEDICINE COALITION,40046362,PERSONALIZED MEDICINE COALITION,2013,second_quarter,MED,"Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2013-07-15T15:05:14.723000-04:00
1407186,97c7ebf1-d122-4b55-9597-94991360390e,Q2,AIR LIQUIDE USA LLC,400596821,AIR LIQUIDE USA LLC,2013,second_quarter,MED,Regulatory and legislative matters related to medical gases and devices.,"Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",,136000,0,0,2013-07-15T15:19:39.333000-04:00
1407326,ab512380-0599-4611-bb04-5888bafbbf95,Q2,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",9375,,0,0,2013-07-15T16:04:39.283000-04:00
1407400,eb9acebc-db43-492f-be6e-cbb9d4930a4a,Q2,ROCK & ASSOCIATES,33545,"BRAIDWOOD MANAGEMENT, INC.",2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",9375,,0,0,2013-07-15T16:35:09.837000-04:00
1407419,7094df03-d02a-4234-962a-3ea487490c0f,Q2,ROCK & ASSOCIATES,33545,CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY),2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-15T16:48:23.153000-04:00
1407462,498fa068-3053-4d32-ac5b-da816d24776b,Q2,ROCK & ASSOCIATES,33545,DIAMONDBACK DRUGS,2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",6750,,0,0,2013-07-15T16:57:42.273000-04:00
1407501,1d8d2c2f-fa5e-420d-a3b4-822ebda287c5,Q2,ROCK & ASSOCIATES,33545,"VETERINARY PHARMACIES OF AMERICA, INC.",2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",9375,,0,0,2013-07-15T17:12:02.090000-04:00
1407541,b9b6673c-dc36-40e8-8941-fe4e67c331d7,Q2,ROCK & ASSOCIATES,33545,"WEDGEWOOD VILLAGE PHARMACY, INC.",2013,second_quarter,MED,"S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.","HOUSE OF REPRESENTATIVES,SENATE",9375,,0,0,2013-07-15T17:26:18.517000-04:00
1407612,57e77e17-6700-4bce-893f-28180d590f3a,Q2,THE OUTLAW GROUP,46095,AMERICAN TINNITUS ASSOCIATION,2013,second_quarter,MED,Legislation to ensure adequate funding of medical research on tinnitus.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-07-15T19:21:00.973000-04:00
1407669,5e71f954-82dc-48fe-8207-9bd56af00db5,Q2,GOLDBUG STRATEGIES LLC,400701094,COALITION FOR 21ST CENTURY MEDICINE,2013,second_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-16T09:30:26.097000-04:00
1407679,ee90fa05-14c6-4694-ba36-50c61e19ddb2,Q2,GOLDBUG STRATEGIES LLC,400701094,LIFE TECHNOLOGIES/THERMO FISHER,2013,second_quarter,MED,"regulation of medical devices, in vitro diagnostics and  laboratory developed tests","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-16T09:37:28.887000-04:00
1407682,e4955a74-bc65-42e4-bdb3-2e0d5f560d1c,Q2,GOLDBUG STRATEGIES LLC,400701094,GENOMIC HEALTH INC.,2013,second_quarter,MED,"FDA regulation of laboratory developed tests.
Medicare reimbursement for laboratory developed tests.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-16T09:43:29.757000-04:00
1408018,66ba37cf-b1e9-416a-b425-bf7598df5c51,Q2,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2013,second_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office",20000,,0,0,2013-07-16T12:06:16.307000-04:00
1408560,ba75dbde-082c-449b-86fb-13f5fec29400,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2013,second_quarter,MED,Research in hematology.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2013-07-16T15:10:14.347000-04:00
1408693,8709778b-e1eb-42fe-b195-140f3cab42f1,Q2,INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS,19822,INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS,2013,second_quarter,MED,The IBEW along with the AFL-CIO lobbied congress against changing the Medicare eligibility age and means testing of the Medicare program.,"Energy, Dept of,HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE",,256319,0,0,2013-07-16T15:32:09.097000-04:00
1408764,0c3d4d17-7909-4976-b980-c6b142632b47,Q2,WEBMD HEALTH CORP.,55473,WEBMD HEALTH CORP,2013,second_quarter,MED,"Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers.  Federal healthcare reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records",SENATE,,30000,0,0,2013-07-16T15:47:35.367000-04:00
1408794,318408bd-5de5-4cf1-ba50-6ab02e6fbf22,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2013,second_quarter,MED,"Appropriations and Authorization legislation for FY 2014 in health care
HR 2397 Department of Defense Appropriations Bill 2014 and Senate bill
HR 2216 Military Construction and Veterans Affairs Appropriations Bill FY2014 and Senate bill","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2013-07-16T15:52:49.083000-04:00
1408865,847d1c4c-00e3-4677-89aa-e1bbf91400bd,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2013,second_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2013-07-16T16:11:21.973000-04:00
1408896,0707585d-0848-482f-9e83-ad0fc4286b99,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2013,second_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2013-07-16T16:13:30.910000-04:00
1408919,0d559b1f-b74b-460f-8345-925438756808,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION OF AMERICA'S BLOOD BANKS,2013,second_quarter,MED,"Blood safety and management issues.  HHS Advisory Committee on Blood Safety and Availability. 
Research related to Biovigilance.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-16T16:15:35.610000-04:00
1409233,db35eb4f-8a79-42f4-9308-63fcfed3df6e,2T,FIRST STRATEGIC,91091,PHOENIX CHILDREN'S HOSPITAL,2013,second_quarter,MED,"Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2013-07-16T19:31:28.347000-04:00
1409356,0724a954-4e93-4def-8551-8d32d0080fce,Q2,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2013,second_quarter,MED,House and Senate FY14 Labor/HHS/Education Appropriations,"HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2013-07-17T09:32:17.607000-04:00
1409392,998f2091-fc1e-4108-924b-4aef5457bc77,2T,BRET HEALY D/B/A RIVERBLUFF STRATEGIES,400581777,"HEALTH EDUCATION RESOURCES AND OUTREACH, INC",2013,second_quarter,MED,Activities in support of a grant application to the Centers for Disease Control for a Type 2 diabetes education and outreach program.,"Health & Human Services, Dept of (HHS),SENATE",10000,,0,1,2013-07-17T09:43:30.153000-04:00
1409525,fda71a80-c9d5-406a-beef-65f0872a9994,Q2,POLICY DIRECTIONS INC.,31747,CHARLES RIVER LABORATORIES,2013,second_quarter,MED,"Pre-clinical research models and drug discovery, development and testing.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-17T10:49:45.973000-04:00
1410240,b5ba20d3-980b-4d17-990f-3806cfeb4f24,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,CRESCENDO BIOSCIENCE INC.,2013,second_quarter,MED,"Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-17T14:46:43.630000-04:00
1410260,7c7bf9cf-7457-4a88-8609-19a925c82f53,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2013,second_quarter,MED,"Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care;  
HR 1309: Health Information Technology Reform Act
HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013","Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",30000,,0,0,2013-07-17T14:50:50.813000-04:00
1410266,d966f71d-9f80-4f18-afea-fd1a4be53075,Q2,"MEHLMAN CONSULTING, INC.",284950,AMERICAN CLINICAL LABORATORY ASSOCIATION,2013,second_quarter,MED,"Health reform law implementation issues including application of medical device tax to clinical laboratory tests and reform of laboratory fee schedule.      
In-office ancillary services exception to Stark Law.    
FDA oversight of laboratory-developed tests.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",80000,,0,0,2013-07-17T14:52:54.263000-04:00
1410280,a526a867-8403-4b60-bbd6-88cbbd0fe0c1,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ONYX PHARMACEUTICALS,2013,second_quarter,MED,"Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages.  Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2013-07-17T14:55:03.030000-04:00
1410310,766539f5-0ce2-4b1d-bac2-64e3799deff3,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,INTERNATIONAL MYELOMA FOUNDATION,2013,second_quarter,MED,"Cancer Drug Coverage Parity Act, H.R. 1801","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-17T14:59:15.743000-04:00
1410958,5a0fafa0-a55e-49de-9073-8ceb3955e3ed,Q2,INTERNATIONAL MYELOMA FOUNDATION,400595820,INTERNATIONAL MYELOMA FOUNDATION,2013,second_quarter,MED,"HR 1801, The Cancer Drug Coverage Parity Act","HOUSE OF REPRESENTATIVES,SENATE",,56000,0,0,2013-07-17T16:57:00.637000-04:00
1411036,5701a8e1-cbf1-4563-9f1d-49ffe857cc0e,Q2,UNIVERSITY OF ROCHESTER,301937,UNIVERSITY OF ROCHESTER,2013,second_quarter,MED,"Public Access
S. 994, Digital Accountability and Transparency (DATA) Act","HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2013-07-17T17:22:20.457000-04:00
1411129,a61f4241-219b-423e-a2d4-ae22436463e2,Q2,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2013,second_quarter,MED,"Appropriations, DOD, TBI research","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-17T18:02:07.930000-04:00
1411237,1fb7003e-2e23-4625-9633-91f4243e3e36,Q2,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2013,second_quarter,MED,"Funding for the USDA ARS human nutrition centers in the FY14 Agricultural Appropriations bills, HR 2410 and S 1244.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-17T18:58:14.943000-04:00
1411979,8477f5f2-6306-46ca-b5f1-46df7e65c72b,Q2,"THE PETRIZZO GROUP, INC.",305932,VULCAN INC -- A PAUL G ALLEN COMPANY,2013,second_quarter,MED,Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2013-07-18T10:41:16.273000-04:00
1412456,0ab40c46-45b0-47a1-8b78-d117f38b3c81,Q2,AMERICAN ACADEMY OF FAMILY PHYSICIANS,1342,AMERICAN ACADEMY OF FAMILY PHYSICIANS,2013,second_quarter,MED,"No Bill Number, ONDCP Drug Control Policy Plan Announcement, AAFP opposes CME mandates for opioid prescribing.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office",,547922,0,0,2013-07-18T11:55:46.623000-04:00
1412631,44fec034-b7ef-4d35-9ba3-672f64399c54,Q2,THORN RUN PARTNERS,400534596,ABBOTT LABORATORIES,2013,second_quarter,MED,"Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.",HOUSE OF REPRESENTATIVES,40000,,0,0,2013-07-18T12:23:49.757000-04:00
1412649,90d906a0-e7d9-42a7-bdea-3b216de63bab,Q2,WASHINGTON UNIVERSITY IN ST. LOUIS,40031264,WASHINGTON UNIVERSITY IN ST LOUIS,2013,second_quarter,MED,"General advocacy for NIH research, genomics research, and improved conflict of interest policies.","HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2013-07-18T12:28:13.207000-04:00
1412684,57106e4a-4b52-40ff-9ee6-8ee4dfc1ab9c,Q2,O'NEILL AND ASSOCIATES,73134,THE JETT FOUNDATION,2013,second_quarter,MED,FDA Issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-07-18T12:39:10.387000-04:00
1412714,becc17b7-2f7c-48db-a9fc-0c5ec60deb8a,Q2,THORN RUN PARTNERS,400534596,CHILDRENS HOSPITAL COLORADO,2013,second_quarter,MED,Issues related to clinical research.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-07-18T12:46:22.033000-04:00
1412915,b9e02363-d45d-489a-824c-41f27c0ac84f,Q2,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2013,second_quarter,MED,NCATS,"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1965000,0,0,2013-07-18T13:24:37.947000-04:00
1412942,b43be892-ad01-45b3-8134-8a65ba9c4e74,Q2,THORN RUN PARTNERS,400534596,NOVARTIS CORPORATION,2013,second_quarter,MED,Issues related to biologics.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-18T13:27:50.837000-04:00
1413327,e73b7a24-f010-48d9-9cdf-dca122c05c48,Q2,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,400382759,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2013,second_quarter,MED,HR 1150-Preservation of Antibiotics for Medical Treatment Act of 2013.,"HOUSE OF REPRESENTATIVES,SENATE",,25208,0,0,2013-07-18T14:44:34.603000-04:00
1414038,ce92342b-a155-42c8-b0e2-2e1b5649a56c,Q2,PRIME POLICY GROUP,400532589,"VERAX BIOMEDICAL, INC.",2013,second_quarter,MED,Blood Safety,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-18T16:04:55.477000-04:00
1414181,ef640e08-5563-462b-8a3d-7ded2d061df4,Q2,ALERE INC.,400647952,ALERE INC.,2013,second_quarter,MED,Development of new and innovative in-vitro diagnostic tests.,"HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)",,159000,0,0,2013-07-18T16:20:48.043000-04:00
1414430,fb2d24d2-448b-4887-b6d9-7cc762fa891c,Q2,"MEDEXPERT CONSULTING, INC.",401061992,"BIOCRYST PHARMACEUTICALS, INC.",2013,second_quarter,MED,Funding for development of medical countermeasures directed against bioterrorism agents that pose a significant threat to public health and national security.,"Defense Threat Reduction Agency (DTRA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-18T16:51:46.377000-04:00
1415321,d6736593-ca19-4bb5-973e-16c1c047060a,Q2,GROUP HEALTH COOPERATIVE,17022,GROUP HEALTH COOPERATIVE,2013,second_quarter,MED,Health systems and medical research topics.,"Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Personnel Management (OPM),SENATE,White House Office",,120000,0,0,2013-07-19T00:40:22.780000-04:00
1415329,463c61de-7e46-4bcd-acb5-daaea107dfa7,Q2,"W STRATEGIES, LLC",400605842,"23ANDME, INC.",2013,second_quarter,MED,Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2013-07-19T01:45:27.840000-04:00
1415557,0933be56-e97e-4ecf-bbdd-4c98e9e1338b,Q2,VAN SCOYOC ASSOCIATES,39837,"STERILUCENT, INC.",2013,second_quarter,MED,"H.R.5856, Department of Defense Appropriations Act, FY2013, Low temperature portable sterilization devices related issues.

H.R.2397, Department of Defense Appropriations Act, FY2014, Low temperature portable sterilization devices related issues.","Army, Dept of (Other),Navy, Dept of,U.S. Marines",20000,,0,0,2013-07-19T07:50:41.620000-04:00
1415756,17e0e29b-070f-4c39-9479-d7eb7bb7184b,Q2,GEORGETOWN UNIVERSITY,62016,GEORGETOWN UNIVERSITY,2013,second_quarter,MED,Regulatory issues involved in domestic research on health benefits of probiotics in yogurt.,"Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE",,20000,0,0,2013-07-19T09:27:38.013000-04:00
1416000,c6323b3a-d14d-4141-bd67-75f1f61043f0,Q2,"CROSSROADS STRATEGIES, LLC",400531586,CONSUMER HEALTHCARE PRODUCTS ASSOCIATION,2013,second_quarter,MED,"S.644, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; Food and Drug Administration Safety and Innovation Act, Public Law No: 112-144; issues related to insuring access to over-the-counter drugs.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2013-07-19T10:06:09.170000-04:00
1416020,6d5e5a39-0a91-44c4-8548-bbec1d04482f,Q2,AMERICAN ACADEMY OF PEDIATRICS,1397,AMERICAN ACADEMY OF PEDIATRICS,2013,second_quarter,MED,"Medical Countermeasures for Children
National Children's Study
Inclusion of Children in Biomedical Research","Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of,White House Office",,112573,0,0,2013-07-19T10:09:18.200000-04:00
1416141,759f3b97-3902-45c6-b5d8-a9f8aa70d788,Q2,"K&L GATES, LLP",32098,SMITS SPEIDELL CONSULTING,2013,second_quarter,MED,Yet to be introduced:  A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2013-07-19T10:27:00.433000-04:00
1416370,870f5f39-7a77-4b4e-aa04-41ab1d7a16fe,Q2,"BAKER BOTTS, L.L.P.",5118,SOUTHERN METHODIST UNIVERSITY,2013,second_quarter,MED,Funding of neurophotonics research for prosthetic devices.,HOUSE OF REPRESENTATIVES,50000,,0,0,2013-07-19T10:56:38.350000-04:00
1416710,bf132d68-aa2f-49b1-848f-ef2ff57ec5e7,Q2,TURNER & GOSS LLP,316310,CANCER LEADERSHIP COUNCIL,2013,second_quarter,MED,"S. 957, Drug Supply Chain Security Act
H.R. 1919, Safeguarding America's Pharmaceuticals Act","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-19T11:28:55.557000-04:00
1417120,acfd5c5d-13d9-4264-a9cd-d26acb1f57cd,Q2,"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC",30212,ASSOCIATION OF MEDICAL DEVICE REPROCESSORS,2013,second_quarter,MED,Monitor and advocate on legislation regarding third party medical device reprocessing.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2013-07-19T12:02:27.720000-04:00
1417432,87500f71-cc7a-4cc9-b6f4-c6fce7e80a38,Q2,FAEGRE DRINKER BIDDLE & REATH LLP,12631,HARM REDUCTION COALITION,2013,second_quarter,MED,Overdose Fatality Prevention Efforts,"Food & Drug Administration (FDA),SENATE",10000,,0,0,2013-07-19T12:32:05.883000-04:00
1417503,bdbb9c1d-b4a4-4c36-b9d2-6f37e44069db,2T,FAEGRE DRINKER BIDDLE & REATH LLP,12631,NATIONAL PSORIASIS FOUNDATION,2013,second_quarter,MED,Psoriasis Data Collection.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,1,2013-07-19T12:39:32.110000-04:00